Patients across the U.S. have been reporting hidden and dangerous side effects in the 2012-era Japanese appetite suppressant Belviq (Lorcaserin). As obesity remains a public health crisis in the U.S., many Americans struggle daily in an effort to lose weight. From 2012 onward, Belviq was introduced in the United States promising meaningful weight loss, and